The study says the two inactivated vaccines developed by Sinopharm prevented symptomatic infections by 72.8% & 78.1%, largely in-line with what the drugmaker previously announced.
Demand is expected to rise if WHO authorises China’s Sinovac & Sinopharm vaccines, allowing developing countries in Asia, Africa & Latin America to access them through Covax.
A notice issued to foreign journalists in Beijing Wednesday said they can get the Inactivated SARS-CoV-2 Vaccine, developed by Sinopharm's China National Biotec Group.
CanSino has applied for regulatory approval in Pakistan and will be give the country preferential access to the single-shot vaccine. Pakistan is yet to start its vaccination drive.
The vaccine has already been administered to hundreds of thousands of people under emergency authorization in China, but it’s yet to receive public use approval from any drug regulators.
Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.
India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.
Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.
COMMENTS